1. Home
  2. OBIO vs NUTX Comparison

OBIO vs NUTX Comparison

Compare OBIO & NUTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OBIO
    SELLHOLDBUYas of a day ago
  • NUTX
    SELLHOLDBUYas of a day ago
  • Stock Information
  • Founded
  • OBIO 2017
  • NUTX 2011
  • Country
  • OBIO United States
  • NUTX United States
  • Employees
  • OBIO N/A
  • NUTX N/A
  • Industry
  • OBIO Medicinal Chemicals and Botanical Products
  • NUTX Retail: Computer Software & Peripheral Equipment
  • Sector
  • OBIO Health Care
  • NUTX Technology
  • Exchange
  • OBIO Nasdaq
  • NUTX Nasdaq
  • Market Cap
  • OBIO 200.1M
  • NUTX 186.1M
  • IPO Year
  • OBIO N/A
  • NUTX N/A
  • Fundamental
  • Price
  • OBIO $4.79
  • NUTX $29.60
  • Analyst Decision
  • OBIO Strong Buy
  • NUTX Strong Buy
  • Analyst Count
  • OBIO 4
  • NUTX 2
  • Target Price
  • OBIO $15.75
  • NUTX $55.00
  • AVG Volume (30 Days)
  • OBIO 57.8K
  • NUTX 43.2K
  • Earning Date
  • OBIO 11-12-2024
  • NUTX 11-07-2024
  • Dividend Yield
  • OBIO N/A
  • NUTX N/A
  • EPS Growth
  • OBIO N/A
  • NUTX N/A
  • EPS
  • OBIO N/A
  • NUTX N/A
  • Revenue
  • OBIO $2,647,000.00
  • NUTX $292,000,390.00
  • Revenue This Year
  • OBIO $12.39
  • NUTX $24.96
  • Revenue Next Year
  • OBIO $120.99
  • NUTX $16.09
  • P/E Ratio
  • OBIO N/A
  • NUTX N/A
  • Revenue Growth
  • OBIO N/A
  • NUTX 26.02
  • 52 Week Low
  • OBIO $4.22
  • NUTX $4.16
  • 52 Week High
  • OBIO $10.44
  • NUTX $41.44
  • Technical
  • Relative Strength Index (RSI)
  • OBIO 37.52
  • NUTX 40.61
  • Support Level
  • OBIO $4.36
  • NUTX $32.42
  • Resistance Level
  • OBIO $5.28
  • NUTX $36.53
  • Average True Range (ATR)
  • OBIO 0.45
  • NUTX 2.89
  • MACD
  • OBIO -0.07
  • NUTX -1.27
  • Stochastic Oscillator
  • OBIO 23.65
  • NUTX 0.00

Stock Price Comparison Chart: OBIO vs NUTX

OBIO
NUTX
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober0510152025303540OBIO VS NUTX

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

About NUTX Nutex Health Inc.

Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use